The new software package is an add-on module to the Medici CIMS, which interfaces with all major electronic medical records (EMR) and clinical laboratory systems. The new module automatically monitors key data points across a hospital's entire information system, including patient records, lab and microbiology results, and medication records; it can identify pharmaceutical intervention opportunities for clinicians, and provide comprehensive reporting on the usage of antimicrobials throughout the hospital in-patient population.

The software enables better ASPs by monitoring appropriate drug-pathogen therapies and potentially inappropriate utilization of antimicrobials, within susceptible patient populations. It also facilitates patient hand-off and helps pharmacists and other infection preventionists provide appropriate therapies for key indicators such as creatinine, international normalized ratio (INR) abnormalities, intravenous (IV) and per os (PO) drug use, and duplicate medication therapy. The Medici clinical information management system and modules are products of Asolva (Los Angeles, CA, USA).

“ASPs are becoming a top priority for hospitals to manage costs and meet licensing and accreditation requirements. For example, the California Department of Public Health has asked all hospitals in the state to implement an ASP,” said Chun Wong, CEO of Asolva. “The shortage of specialists and trained personnel to implement an ASP is a big concern for hospitals. Medici can help pharmacists and other clinicians evaluate and enhance their antimicrobial management efforts, reducing HAIs and enhancing the ASP.”

Related Links:
Asolva